Table 1.
Use and pharmaceutical expenditures on antihypertensive and antihyperlipidemic drugs.
Table 2.
Use and spending on antihypertensive and antihyperlipidemic drugs by age.
Table 3.
Use and pharmaceutical expenditures for antihypertensive drugs by therapeutic class.
Table 4.
Use and spending on antihypertensive and antihyperlipidemic drugs by ATC class and single versus combination.
Fig 1.
Drug spending on antihypertensive and antihyperlipidemic drugs by ingredients.
Note. C02CA04: doxazosin, C03AA03: hydrochlorothiazide, C03CA01: furosemide, C03DA01: spironolactone, C07AG02: carvedilol, C07AB12: nebivolol, C07AB07: bisoprolol, C07AB03: atenolol, C07AA05: betaxolol, C08CA01: amlodipine, C08CA05: nifedipine, C08DB01: diltiazem, C08CA13: lercanidipine, C08CA02: felodipine, C08CA14: cilnidipine, C09DB04: telmisartan+amlodipine, C09DB01: valsartan+amlodipine, C09DB02: olmesartan medoxomil+amlodipine, C09DB06: losartan+amlodipine, C09DA01: losartan+diuretics, C09CA01: losartan, C09CA06: candesartan, C09DX03: olmesartan, edoxomil, amlodipine+hydrochlorothiazide, C09CA03: valsartan, C09CA07: telmisartan, C09DA03: valsartan+diuretics, C09DA06: candesartan+diuretics, C09DA07: telmisartan+diuretics, C09CA08: olmesartan medoxomil+diuretics, C09CA10: fimasartan, C09DB07: candesartan+amlodipine, C09DA08: olmesartan medoxomil+diuretics, C09CA04: irbesartan, C10AA05: atorvastatin, C10AA07: rosuvastatin, C10BA06: rosuvastatin+ezetimibe, C10AA08: pitavastatin, C10AB05: fenofibrate, C10BA05:atorvastatin+ezetimibe, C10BX03: atorvastatin+amlodipine, C10BA02: simvastatin+ezetimibe, C10BA03: pravastatin+fenofibrate, C10AB11: choline fenofibrate, C10AA01: simvastatin, C10AA03: pravastatin, C10BX10: rosuvastatin+valsartan.